Страна: Ірландія
мова: англійська
Джерело: HPRA (Health Products Regulatory Authority)
DEXAMETHASONE
Organon (Ireland) Limited
2 Milligram
Tablets
2007-01-12
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Dexamethasone Tablets 2mg. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 2mg of Dexamethasone. Excipients: Each tablet contains approximately 116mg lactose monohydrate. For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Tablet. Round, 6 mm, flat, white tablet with the code ‘XC/8’ engraved on one surface and ‘Organon*’ on the other. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Dexamethasone tablets are used for the treatment of various inflammatory and autoimmune diseases e.g.: RHEUMATISM, as pain, stiffness or limitation of motion, especially in the joints and related structures, including muscles, bursae, tendons, fibrous tissue; COLLAGEN DISEASE, as lupus erythematosus, dermatomyositis, polyarteritis nodosa, thrombotic purpura and rheumatoid arthritis; ALLERGIES, as status asthmaticus, bronchial asthma, contact dermatitis, inflammatory processes of the eye and its adnexa, severe hypersensitivity reactions to drugs or insect stings, anaphylactic shock, impending allograft rejection; PRIMARY OR SECONDARY ADRENOCORTICAL INSUFFICIENCY, and ADRENOGENITAL SYNDROMES. Besides Dexamethasone is used as an adjunct in the control of CEREBRAL OEDEMA (not in those cases where the oedema is caused by head injury), for treatment of LYMPHOCYTIC LEUKAEMIA, as ANTI-EMETIC in antineoplastic regimens and for palliative treatment in terminal stages of NEOPLASTIC DISEASE. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Glucocorticoids may be administered by a number of routes, depending on the nature of the disease and the condition of the patient. Localised therapy is generally preferred because it minimises adverse effects. When systemic administration is required, the oral route is preferred for ease i Прочитайте повний документ